Frequently mutated SAMHD1 found in colon cancers was suggested to be involved in tumorigenesis with defective mismatch repair (MMR) (49) and also act as a resistance factor for anticancer drugs (50). This evidence concerns the gene SAMHD1 and malignant colon neoplasm.